Kaitai Capital
凯泰资本
Kaitai Capital (凯泰资本) is a venture capital fund that appears in elsewhere's corpus primarily through its investment activity in Chinese tech and biotech startups from 2022 to 2023. It led a tens-of-millions RMB round in Beijing-based open-source software company White Whale Open Source in July 2022 , and participated as a follow-on investor in Xinchen AI's Pre-A and subsequent strategic rounds alongside Baidu Venture Capital and others in 2023 . It also backed Bivision Pharmaceuticals' nearly RMB 100 million angel round in August 2022 . The fund does not appear as the authored subject of any coverage in the retrieved material — elsewhere's corpus does not provide its founding date, AUM, team composition, or investment thesis.
AI-generated — may contain errors, please verify.